Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19

Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and severe microthrombi and microvascular obliterative disease. It is hypothesized that those patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pulm Circ
Hlavní autoři: Franco, Veronica, Bradley, Elisa A., Badagliacca, Roberto, Sabanayagam, Aarthi, Rajpal, Saurabh, Lastinger, Lauren T., Daniels, Curt J., Smith, J. Shaun, Benza, Raymond L.
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Leading Edge Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686637/
https://ncbi.nlm.nih.gov/pubmed/33282201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020970369
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky